Navigation Links
New Treatment Combo Better Against Hepatitis C
Date:4/29/2009

Adding antiviral telaprevir increases cure rate, studies show,,,,

WEDNESDAY, April 29 (HealthDay News) -- Adding the antiviral drug telaprevir to standard treatment for hepatitis C increases the cure rate, two new studies show.

Current treatment for hepatitis C (HCV) genotype 1, the most common subtype, is a combination of two drugs, pegylated interferon and ribavirin, given over 48 weeks. This treatment cures less than half of patients and has side effects that make it difficult for some patients to complete the treatment, researchers say. Both reports are published in the April 30 issue of the New England Journal of Medicine.

"Hepatitis C is curable," said the lead researcher of the first study Dr. Jean-Michel Pawlotsky, from the Henri Mondor Hospital, University of Paris, in France. "Currently, 40 to 50 percent of patients infected with HCV genotype 1 can be cured by standard of care, but nothing can be offered to the patients who are unable to eradicate infection on treatment."

For the study, Pawlotsky's team randomly assigned 334 patients with HCV to one of four treatment combinations of telaprevir, peginterferon and ribavirin

The results show that, by using a triple combination of telaprevir, pegylated interferon and ribavirin for 12 weeks, followed by 12 weeks of pegylated interferon and ribavirin, a sustained viral eradication can be achieved in 69 percent of cases, whereas only 46 percent of patients receiving standard of care for 48 weeks achieve a cure, Pawlotsky said.

"This is a breakthrough in HCV therapy," Pawlotsky said. "For the very first time, almost 70 percent cure rates are reached."

These findings open the way to an ongoing phase 3 trial, which could lead to the approval of this combination within the next two years, he said. "The triple combination could become the new standard of care," he noted.

In the second study, Dr. John G. McHutchison, a
'/>"/>

Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. New Treatment Discovered for Restless Legs Syndrome Improves Sleep
2. Free Treatment for Breast Cancer Available in Pennsylvania
3. Zebrafish offer clues to treatments for motor neurone disease
4. New Analyses from 16-Year Follow-up Trial with Betaseron(R) Demonstrated that Early and Sustained Treatment of Multiple Sclerosis Patients Enrolled in the Trial Affected Their Long-term Outcomes
5. Varicose Veins Pose Scary Health Risk; Sufferers Find Solace With Insurance-Covered Treatment at Renaissance Laser and Vein Institute
6. Study finds higher drug co-pays discourage patients from starting treatment
7. A Call to Action: NGOs Working in Blindness Prevention and Treatment Convene Special Forum to Address Gender and Eye Health
8. Turtle Island Oxygen Trust Sponsors Free Hyperbaric Treatments
9. Product Shifts are Occurring in the Renal Anemia and Bone and Mineral Metabolism Markets According to the Most Recent TreatmentTrends(R): US Nephrology Report from BioTrends Research Group
10. Different treatment options in chronic coronary artery disease
11. Wyeths CONBRIZA Approved in the European Union for Treatment of Postmenopausal Osteoporosis in Women at Increased Risk of Fracture
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Treatment Combo Better Against Hepatitis C
(Date:9/2/2014)... MD (PRWEB) September 02, 2014 ... model within the primary and urgent care arena, ... This opening coincides with a health fair the ... care incorporating technology to assist patients in achieving ... Evolve Medical Clinics’ pricing structure is a groundbreaking ...
(Date:9/2/2014)... September 02, 2014 Last year, SIGVARIS ... with the launch of a luxurious line of graduated compression ... the SEA ISLAND COTTON Socks are joining the SIGVARIS MEDICAL ... more people the comfort of natural cotton fibers. , ... are surprised to find socks as soft as the finest ...
(Date:9/2/2014)... York, NY (PRWEB) September 02, 2014 ... soccer tickets. The first week in September will be ... Teams from Brazil, Colombia, Mexico, Chile, Ecuador and Bolivia ... The following matches will take place between September 5th - ... Stadium on Tuesday, September 9th , Mexico vs. ...
(Date:9/2/2014)... York, NY (PRWEB) September 02, 2014 ... VisitandCare.com , was designed to help doctors manage ... practices to boost patient conversion rates and clink revenue. ... a 60 percent increase in sales revenue and a ... one-of-a-kind CRM software in their own healthcare practices. , ...
(Date:9/2/2014)... hospitalized, but your outpatient doctor does not know? ... follow-up care, but your doctor does not have ... Missing or incomplete communication from hospitals to outpatient ... experiences and lead to hospital readmissions. , ... can improve hospitals, communication during patient care transitions. ...
Breaking Medicine News(10 mins):Health News:Evolve Medical Clinics Announces Grand Opening of Annapolis, Maryland Location 2Health News:Evolve Medical Clinics Announces Grand Opening of Annapolis, Maryland Location 3Health News:SIGVARIS’ Luxury Line of Compression Socks, SEA ISLAND COTTON, Now Available in Stronger Compression Level 2Health News:Ticket Down Substantially Slashes Ticket Prices on Brazil vs. Ecuador Tickets, Brazil vs. Colombia Tickets, Mexico vs. Chile Tickets and Mexico vs. Bolivia Tickets 2Health News:Ticket Down Substantially Slashes Ticket Prices on Brazil vs. Ecuador Tickets, Brazil vs. Colombia Tickets, Mexico vs. Chile Tickets and Mexico vs. Bolivia Tickets 3Health News:Doctors Abroad Using VisitandCare.com Patient Management Software Report 60% Increase in Revenue 2Health News:Doctors Abroad Using VisitandCare.com Patient Management Software Report 60% Increase in Revenue 3Health News:Doctors Abroad Using VisitandCare.com Patient Management Software Report 60% Increase in Revenue 4Health News:Can data motivate hospital leaders to improve care transitions? 2
... Data presented today at the International Conference ... that Perforomist™ Inhalation Solution (formoterol fumarate inhalation ... profile that is comparable to the dry ... Foradil® Aerolizer® 12 g (FA). , ...
... Reports of children becoming unconscious after swallowing Aqua Dots beads ... 2007. At the time, it was widely reported that the ... of the benign but more expensive 1,5-pentanediol (PD) in the ... Dr. Jeffrey Suchard of the University of California, Irvine confirms ...
... Ground-breaking research reveals more about the effects of ... 20 The American Heart,Association estimates that one ... disease, and that cardiovascular disease is the largest,major ... research into mechanisms,behind fighting heart disease is welcome ...
... May 20 /PRNewswire-USNewswire/.- Speaker Nancy Pelosi,issued the following statement ... news of Senator Kennedy,s health has been met with ... health care for all Americans and a,great fighter for ... and fighting spirit will serve him well in this,challenge., ...
... ,Medal of Honor, books and DVDs to local schools, ... of over 100 local,school children and military dignitaries, TriWest ... present the best-selling,book "Medal of Honor: Portraits of Valor ... San Diego County School Board as one of 5,300,copies ...
... the ... globe., DENVER, ... motion preserving, total disc replacement devices,announced today that the Company will provide ... The foremost scientific societies dedicated to the study and treatment,of disorders of ...
Cached Medicine News:Health News:Perforomist-comparable pharmacokinetic and pharmacodynamic profile to DPI formulation 2Health News:Study finds that recalled Aqua Dots did contain poisonous chemical 2Health News:When It comes to Matters of the Heart, Almonds Are a Multi-Tasker 2Health News:When It comes to Matters of the Heart, Almonds Are a Multi-Tasker 3Health News:When It comes to Matters of the Heart, Almonds Are a Multi-Tasker 4Health News:When It comes to Matters of the Heart, Almonds Are a Multi-Tasker 5Health News:5,000 California Schools Receive Book About Sacrifice, Courage 2Health News:C5 Medical Werks Joins in Sponsoring SpineWeek 2008 in Geneva, Switzerland 2
(Date:9/2/2014)... , Sept. 2, 2014  Cyberonics, Inc. ... from the ANTHEM-HF clinical study.  Results of the ... during a major European cardiology congress and concurrently ... show Autonomic Regulation Therapy (ART) in patients ... impaired heart function is safe, improves the heart,s ...
(Date:9/2/2014)... , Sept. 2, 2014  Volcano Corporation ... focused on improving patient and economic outcomes on ... minimally invasive coronary and peripheral visualization, physiology diagnostics ... participating in the Morgan Stanley Healthcare conference on ... Scott Huennekens , president and chief executive ...
(Date:9/2/2014)... 2, 2014  BioSpecifics Technologies Corp. (NASDAQ: BSTC ... marketed as XIAFLEX ® in the U.S. and XIAPEX ... Tom Wegman , will present at the following upcoming ... & Renshaw 16 th Annual Global ... Tuesday, September 9, 2014 at 9:10 a.m. EDT , ...
Breaking Medicine Technology:ANTHEM-HF Shows Autonomic Regulation Therapy Is Safe And Improves Heart Function In Patients With Chronic Heart Failure 2ANTHEM-HF Shows Autonomic Regulation Therapy Is Safe And Improves Heart Function In Patients With Chronic Heart Failure 3ANTHEM-HF Shows Autonomic Regulation Therapy Is Safe And Improves Heart Function In Patients With Chronic Heart Failure 4ANTHEM-HF Shows Autonomic Regulation Therapy Is Safe And Improves Heart Function In Patients With Chronic Heart Failure 5BioSpecifics Technologies Corp. Announces Presentations at Upcoming Investor Conferences 2
... medication with published data,demonstrating symptom control at 13 ... Oct. 29 Shire plc (LSE: SHP, Nasdaq:,SHPGY), ... a 13-hour analog classroom study in school-aged children ... Disorder (ADHD). In this,study, researchers found that VYVANSE ...
... Zealand and Canada Find Ruyan E-cigarettes Safe; ... Results Apply Only to Ruyan Products, ... publication of a report that tested the safety of its ... that users find satisfies their desire for tobacco. The,report summary ...
Cached Medicine Technology:Recent Study Demonstrated VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Improvements in Behavior, Inattention, and Math Test Scores from 1.5 Hours up to 13 Hours following Administration in Children with ADHD 2Recent Study Demonstrated VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Improvements in Behavior, Inattention, and Math Test Scores from 1.5 Hours up to 13 Hours following Administration in Children with ADHD 3Recent Study Demonstrated VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Improvements in Behavior, Inattention, and Math Test Scores from 1.5 Hours up to 13 Hours following Administration in Children with ADHD 4Recent Study Demonstrated VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Improvements in Behavior, Inattention, and Math Test Scores from 1.5 Hours up to 13 Hours following Administration in Children with ADHD 5Recent Study Demonstrated VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Improvements in Behavior, Inattention, and Math Test Scores from 1.5 Hours up to 13 Hours following Administration in Children with ADHD 6Recent Study Demonstrated VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Improvements in Behavior, Inattention, and Math Test Scores from 1.5 Hours up to 13 Hours following Administration in Children with ADHD 7Comprehensive Safety Tests Published on Ruyan(R) Smoking Alternatives 2Comprehensive Safety Tests Published on Ruyan(R) Smoking Alternatives 3
Monitorr ICP external CSF drainage and monitoring system with patient line one way valve....
... and skull base surgery. Complete implant ... pediatric neurosurgery, bony defects of the ... regions, neuro trauma. Dedicated neuro/skull base ... one compact kit. MRI and CT ...
Ralk Hand Drill, with Jacobs chuck, wrench-locking, with axial channel for Kirschner wires, for twist drills up to 7 mm , for Kirschner wires up to 4 mm...
Hudson Cranial Drill, complete, consisting of: brace; with extension piece and 4 burs...
Medicine Products: